All In Biotech

Free tool

FAERS Monitor: Sotalol Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022306 or its brand name (Sotalol Hydrochloride, Sotalol Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,515

Serious

2,111

84% of reports

Hospitalization

1,122

Death reported

254

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • atrial fibrillation171
  • electrocardiogram qt prolonged148
  • drug ineffective143
  • hypotension123
  • dyspnoea117
  • bradycardia111
  • dizziness110
  • drug interaction99
  • nausea93
  • fatigue92
  • fall86
  • acute kidney injury72
  • ventricular tachycardia72
  • off label use71
  • asthenia63

Reports by year received

View as table
YearReports
200446
200531
2006127
2007234
200830
2009123
201030
201179
2012107
201357
201466
201554
201676
201795
2018123
2019146
2020110
202194
2022139
2023149
2024193
2025253
2026153

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,644 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
ventricular tachycardiaSignal7236.629.12,450
electrocardiogram qt prolongedSignal14834.629.54,777
bradycardiaSignal11117.514.61,716
atrial fibrillationSignal17114.712.72,177
drug interactionSignal995.24.3336
hypotensionSignal1235.14.3409
acute kidney injurySignal723.93.1156
fallSignal862.21.853
dizziness1101.81.543
dyspnoea1171.71.436
asthenia631.41.17
fatigue921.00.80
nausea931.00.80
drug ineffective1430.90.81
off label use710.70.511

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.